NCT04260685View on ClinicalTrials.gov

Lidocaine Versus Esmolol for Optimizing Surgical Field Visibility

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

June 15, 2020

Study Completion Date

June 30, 2020

Conditions
Lumbar Disc Herniation
Interventions
DRUG

Lidocaine

IV bolus of 1.5mg/kg lidocaine 1% followed by continuous infusion of 1.5mg/kg/h

DRUG

Esmolol

IV bolus of esmolol 0.5 mg/kg followed by continuous infusion of 100-300 ug/kg/min

Trial Locations (1)

022/055

Faculty of Medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04260685 - Lidocaine Versus Esmolol for Optimizing Surgical Field Visibility | Biotech Hunter | Biotech Hunter